Big congratulations to @SusanKilgas, who won a Poster Presentation Award at the 20th International p53 Workshop | p53 Conference, which took place last week in Toronto!
Fantastic work! #p53biology
Our co-founder and scientific lead, Susan, recently attended the Gordon Research Conference (2026: DNA Damage, Mutation, and Cancer) held March 1–6, 2026, in California. She chaired the Gordon Research Seminar (GRS), delivered a talk, and presented a poster that won first place.
Congratulations to @ChiaraMasnovo on receiving the @AmericanCancer Postdoctoral Fellowship! 🎉 Her project will be defining the DNA Repair Independent Mitotic Role of 53BP1
Mentor: Dipanjan Chowdhury
Co-mentor: Alexander Spektor
Well deserved recognition of outstanding work! 👏
Congratulations to @SusanKilgas on receiving the first place Best Poster Award at the DNA Damage Mutation and Cancer Gordon Research Conference for her poster on a novel layer of p53 regulation through TIRR 🎉
🔬 Happy International Women’s Day from GambitBio! 🌍✨
We’re celebrating the women behind our mission to transform cancer detection.
Here’s to lifting each other up, building bold ideas, and creating breakthroughs that change the world. 💪✨
#InternationalWomensDay
Trainees in genome stability 🧬: There’s still time to register for the 2026 Gordon Research Seminar (Feb 28–Mar 1, 2026)! Poster & talk abstracts accepted until Dec 30, 2025. Huge thanks to our supporters: Pfizer, The Company of Biologists, CST & the Karlseder Lab.
🧬 Grad students and postdocs in DNA repair/DDR: don’t forget to register for the 2026 GRS “Safeguarding the Genome” seminar — Feb 28–Mar 1, Ventura, CA. Keynote: @ChowdhuryLab. Abstracts due by Nov 23, 2025. Register here: 🔗 https://t.co/ysUWlLVZcr
🧬Register for the GRS on DNA Damage, Mutation & Cancer🧬 @GordonConf
Feb 28–Mar 1 2026, Ventura CA
Accepting abstracts for oral presentations! 📍 Apply here 👉 https://t.co/wrWjSNYLp8
#DNADamage#GRC#GRS#CallForAbstracts
Excited to share our new paper from Sara J. Buhrlage lab & @ChowdhuryLab! We designed CAS-010, a selective, low nanomolar USP28 inhibitor that reduces p53 transcriptional activity, mimics p53 pathway loss & disrupts 53BP1-USP28 binding, offering new insights into USP28 function.
🧬 Grad students and postdocs in DNA repair/DDR: don’t forget to register for the 2026 GRS “Safeguarding the Genome” seminar — Feb 28–Mar 1, Ventura, CA. Keynote: @ChowdhuryLab. Abstracts due by Nov 23, 2025. Register here: 🔗 https://t.co/ysUWlLVZcr
Excited to share our publication out in Science today! We define a role for the CST complex in DSB repair pathway choice. This study was conducted in close collaboration with Patrick Sung’s lab. Congratulations to Michelle Swift and all other authors! https://t.co/aEphViFGnV
My friend @tiffany_s_ma has a startup focussed on early detection of cancer - could you please take her survey?
It's gauging demand and ideas about early cancer detection kits: https://t.co/xZZQcvkqgg
Grateful to contribute to this @NatureCancer Viewpoint reflecting on my 1st year as an independent investigator @DanaFarber 👩🔬Thanks to lab members, mentors, collaborators, friends, & family who have supported me in 2024!Let's see what 2025 brings💫✨💡 https://t.co/vieWHL2dcM
#qTAG: Laurence Pelletier @laurpelletier and coworkers present an adaptable set of optimized #CRISPR repair cassettes for streamlined endogenous tagging, enabling diverse applications in functional protein studies within their native regulatory context
https://t.co/Xp5VpyrVNn